Tokyo Tape
Sign in
← DyDo Group Holdings

Quarterly report · Q1

2590.TEDINET S100O6IT
Period2022-01-21 → 2022-04-20
Filed2022-06-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥34.8bn2022-01-21 → 2022-04-20Cons.Net sales
Revenue¥162.6bn2021-01-21 → 2022-01-20Cons.Net sales (5-year summary)
Revenue¥36.1bn2021-01-21 → 2021-04-20Cons.Net sales
Operating income−¥692m2022-01-21 → 2022-04-20Cons.Operating income
Operating income¥426m2021-01-21 → 2021-04-20Cons.Operating income
Ordinary income−¥585m2022-01-21 → 2022-04-20Cons.Ordinary income
Ordinary income¥5.7bn2021-01-21 → 2022-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥400m2021-01-21 → 2021-04-20Cons.Ordinary income
Profit before tax−¥676m2022-01-21 → 2022-04-20Cons.Income before income taxes
Profit before tax¥431m2021-01-21 → 2021-04-20Cons.Income before income taxes
Net income (owners)−¥857m2022-01-21 → 2022-04-20Cons.Profit loss attributable to owners of parent
Net income (owners)¥4.0bn2021-01-21 → 2022-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥229m2021-01-21 → 2021-04-20Cons.Profit loss attributable to owners of parent
Net income−¥860m2022-01-21 → 2022-04-20Cons.Profit loss
Net income¥217m2021-01-21 → 2021-04-20Cons.Profit loss
Total assets¥163.8bnat 2022-04-20Cons.Assets
Total assets¥159.0bnat 2022-01-20Cons.Assets
Total assets¥163.5bnat 2021-04-20Cons.Total assets (5-year summary)
Total liabilities¥82.1bnat 2022-04-20Cons.Liabilities
Total liabilities¥75.7bnat 2022-01-20Cons.Liabilities
Net assets / equity¥81.7bnat 2022-04-20Cons.Net assets
Net assets / equity¥83.3bnat 2022-01-20Cons.Net assets
Net assets / equity¥83.8bnat 2021-04-20Cons.Net assets (5-year summary)
Cash and deposits¥27.4bnat 2022-04-20Cons.Cash and deposits
Cash and deposits¥27.6bnat 2022-01-20Cons.Cash and deposits
EPS (basic)¥-54.782022-01-21 → 2022-04-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥254.22021-01-21 → 2022-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.722021-01-21 → 2021-04-20Cons.Basic earnings loss per share (5-year summary)
Equity ratio49.6%at 2022-04-20Cons.Equity to asset ratio (5-year summary)
Equity ratio52.1%at 2022-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2021-04-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-04-20−¥134m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-04-20−¥134m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-04-20−¥270m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥24.8bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥24.8bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥12m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥325m
jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-04-20−¥96m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥1m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-04-20¥234m
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥3.0bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥3.0bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥205m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-04-20¥2.9bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-04-20¥2.7bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-04-20¥120m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-04-20−¥28m
—segment totalrevenue2022-01-21 → 2022-04-20¥34.9bn
—segment totalrevenue external2022-01-21 → 2022-04-20¥34.8bn
—segment totalrevenue intersegment2022-01-21 → 2022-04-20¥134m
—segment totalsegment profit2022-01-21 → 2022-04-20−¥422m
Reconciling Itemsreconcilingrevenue2021-01-21 → 2021-04-20−¥126m
Reconciling Itemsreconcilingrevenue intersegment2021-01-21 → 2021-04-20−¥126m
Reconciling Itemsreconcilingsegment profit2021-01-21 → 2021-04-20−¥367m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥26.9bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥26.9bn
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥15m
jpcrp040300-q1r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥707m
jpcrp040300-q1r_E00424-000Dy Do Pharmareportable segmentsegment profit2021-01-21 → 2021-04-20−¥44m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥4.3bn
jpcrp040300-q1r_E00424-000Food Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥1m
jpcrp040300-q1r_E00424-000Food Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥143m
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥2.4bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥2.4bn
jpcrp040300-q1r_E00424-000International Beverage Businessreportable segmentsegment profit2021-01-21 → 2021-04-20−¥30m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2021-01-21 → 2021-04-20¥2.7bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2021-01-21 → 2021-04-20¥2.6bn
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2021-01-21 → 2021-04-20¥109m
jpcrp040300-q1r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2021-01-21 → 2021-04-20¥17m
—segment totalrevenue2021-01-21 → 2021-04-20¥36.3bn
—segment totalrevenue external2021-01-21 → 2021-04-20¥36.1bn
—segment totalrevenue intersegment2021-01-21 → 2021-04-20¥126m
—segment totalsegment profit2021-01-21 → 2021-04-20¥793m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 393
ItemContextValueUnit
AssetsCurrentQuarterInstant163808000000JPY
Notes and accounts payable tradePrior1YearInstant17148000000JPY
Notes and accounts payable tradeCurrentQuarterInstant20819000000JPY
Current portion of long term loans payablePrior1YearInstant3748000000JPY
Current portion of long term loans payableCurrentQuarterInstant4211000000JPY
Accounts payable otherPrior1YearInstant10919000000JPY
Accounts payable otherCurrentQuarterInstant11040000000JPY
Income taxes payablePrior1YearInstant1796000000JPY
Income taxes payableCurrentQuarterInstant515000000JPY
Provision for bonusesPrior1YearInstant1230000000JPY
Provision for bonusesCurrentQuarterInstant1966000000JPY
Provision for directors bonusesPrior1YearInstant－JPY
Provision for directors bonusesCurrentQuarterInstant10000000JPY
Other clPrior1YearInstant3919000000JPY
Other clCurrentQuarterInstant3998000000JPY
Current liabilitiesPrior1YearInstant38764000000JPY
Current liabilitiesCurrentQuarterInstant42562000000JPY
Bonds payablePrior1YearInstant20000000000JPY
Bonds payableCurrentQuarterInstant20000000000JPY
Long term loans payablePrior1YearInstant7265000000JPY
Long term loans payableCurrentQuarterInstant9973000000JPY
Provision for directors retirement benefitsPrior1YearInstant169000000JPY
Provision for directors retirement benefitsCurrentQuarterInstant170000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant131000000JPY
Provision for share based remuneration for directors and other officers nclCurrentQuarterInstant125000000JPY
Net defined benefit liabilityPrior1YearInstant558000000JPY
Net defined benefit liabilityCurrentQuarterInstant230000000JPY
Other nclPrior1YearInstant8833000000JPY
Other nclCurrentQuarterInstant9023000000JPY
Noncurrent liabilitiesPrior1YearInstant36958000000JPY
Noncurrent liabilitiesCurrentQuarterInstant39523000000JPY
LiabilitiesPrior1YearInstant75722000000JPY
LiabilitiesCurrentQuarterInstant82085000000JPY
Capital stockPrior1YearInstant1924000000JPY
Capital stockCurrentQuarterInstant1924000000JPY
Capital surplusPrior1YearInstant374000000JPY
Capital surplusCurrentQuarterInstant374000000JPY
Retained earningsPrior1YearInstant90715000000JPY
Retained earningsCurrentQuarterInstant89544000000JPY
Treasury stockPrior1YearInstant-4231000000JPY
Treasury stockCurrentQuarterInstant-4199000000JPY
Shareholders equityPrior1YearInstant88781000000JPY
Shareholders equityCurrentQuarterInstant87643000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant6798000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6708000000JPY
Deferred gains or losses on hedgesPrior1YearInstant484000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant693000000JPY
Foreign currency translation adjustmentPrior1YearInstant-13543000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant-14007000000JPY
Remeasurements of defined benefit plansPrior1YearInstant289000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-01-20pass rounding
balance sheet identityconsolidated 2022-04-20pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-01-20pass
statement vs summary · net assetsconsolidated 2022-04-20pass
statement vs summary · net income attributable to parentconsolidated 2021-01-21/2021-04-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-04-20pass
statement vs summary · revenueconsolidated 2021-01-21/2021-04-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-04-20pass
statement vs summary · total assetsconsolidated 2022-01-20pass
statement vs summary · total assetsconsolidated 2022-04-20pass